SMC recommends Bayer’s cancer treatments for NHS Scotland use
Eligible patients in Scotland will now have access to Nubeqa and Stivarga
Read More
Tag: docetaxel
UK trial for new bladder cancer therapy
An experimental therapy for bladder cancer in on the brink of entering Phase I clinical trials in the UK after a development pact was signed between Cancer Research UK, its commercial arm Cancer Research Technology, and Canadian biotech Sitka Biopharma.
Read More
PhIII data show benefit of Tecentriq on lung cancer survival
Late-stage trial data published in The Lancet show that Roche’s Tecentriq significantly extended survival in patients with previously-treated advanced non-small cell lung cancer taking the immunotherapy versus those on chemotherapy.
Read More
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
